Clinion Launches Revolutionary AI-Powered Medical Coding Solution for Clinical Trials

Clinion, a leading provider of eClinical solutions, has unveiled its AI-powered Medical Coding solution designed to transform the way medical data is coded in clinical trials. This innovative solution delivers faster, more accurate, and highly efficient medical coding, helping clinical trial teams streamline data management and accelerate decision-making.

Medical coding is a critical part of clinical trials, enabling researchers to accurately capture, classify, and analyze medical information. Traditional manual coding can be slow, labor-intensive, and prone to errors, often causing delays in trial timelines and increasing operational costs.

Clinion’s AI Medical Coding solution leverages advanced machine learning algorithms to automate the coding process, assigning appropriate medical codes according to internationally recognized standards, including MedDRA and WHO Drug Dictionary (WHODD). By providing real-time coding and feedback, the solution allows clinical teams to make informed, data-driven decisions quickly and efficiently, while maintaining high standards of accuracy and compliance.

This new solution complements Clinion’s existing suite of eClinical tools, which includes Electronic Data Capture (EDC), RTSM, ePRO, eConsent, and CTMS. Already used in over 500 clinical trials, Clinion continues to support sponsors, CROs, and research teams in conducting trials with greater speed, precision, and reliability.

With the launch of AI Medical Coding, Clinion reinforces its position among top clinical trial technology companies and its commitment to leveraging artificial intelligence to drive innovation across the clinical trial lifecycle, enabling faster access to new treatments and improving the overall efficiency of clinical research.